DK0984936T3 - Cyanoguanidiner som celleproliferationsinhibitorer - Google Patents
Cyanoguanidiner som celleproliferationsinhibitorerInfo
- Publication number
- DK0984936T3 DK0984936T3 DK98924052T DK98924052T DK0984936T3 DK 0984936 T3 DK0984936 T3 DK 0984936T3 DK 98924052 T DK98924052 T DK 98924052T DK 98924052 T DK98924052 T DK 98924052T DK 0984936 T3 DK0984936 T3 DK 0984936T3
- Authority
- DK
- Denmark
- Prior art keywords
- stands
- cyanoguanidines
- alkoxycarbonyl
- carboxy
- alkoxy
- Prior art date
Links
- 230000004663 cell proliferation Effects 0.000 title 1
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical class NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 nitro, amino Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9711123.1A GB9711123D0 (en) | 1997-05-29 | 1997-05-29 | Novel cyanoguanidines |
| PCT/DK1998/000193 WO1998054141A1 (en) | 1997-05-29 | 1998-05-15 | Cyanoguanidines as cell proliferation inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0984936T3 true DK0984936T3 (da) | 2004-01-05 |
Family
ID=10813253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98924052T DK0984936T3 (da) | 1997-05-29 | 1998-05-15 | Cyanoguanidiner som celleproliferationsinhibitorer |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6346520B1 (da) |
| EP (1) | EP0984936B1 (da) |
| JP (1) | JP4349476B2 (da) |
| KR (1) | KR100549631B1 (da) |
| CN (1) | CN1121389C (da) |
| AT (1) | ATE248819T1 (da) |
| AU (1) | AU733000B2 (da) |
| CA (1) | CA2292775C (da) |
| CZ (1) | CZ293275B6 (da) |
| DE (1) | DE69817810T2 (da) |
| DK (1) | DK0984936T3 (da) |
| ES (1) | ES2206931T3 (da) |
| GB (1) | GB9711123D0 (da) |
| HU (1) | HUP0003823A3 (da) |
| NZ (1) | NZ501266A (da) |
| PL (1) | PL190249B1 (da) |
| PT (1) | PT984936E (da) |
| RO (1) | RO119880B1 (da) |
| RU (1) | RU2194697C2 (da) |
| WO (1) | WO1998054141A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000061561A1 (en) | 1999-04-09 | 2000-10-19 | Shionogi Bioresearch Corp. | Cyanoguanidine compounds |
| AU1494702A (en) | 2000-11-21 | 2002-06-03 | Leo Pharma As | Cyanoguanidine prodrugs |
| US20030045515A1 (en) * | 2001-05-24 | 2003-03-06 | Lise Binderup | Combination medicament for treatment of neoplastic diseases |
| KR20030097897A (ko) * | 2001-05-24 | 2003-12-31 | 레오 파마 에이/에스 | 신규한 피리딜 시아노구아니딘 화합물 |
| US7253193B2 (en) | 2002-05-17 | 2007-08-07 | Leo Pharma A/S | Cyanoguanidine prodrugs |
| AU2003229534B2 (en) * | 2002-05-17 | 2009-08-27 | Leo Pharma A/S | Cyanoguanidine prodrugs |
| WO2006066584A1 (en) | 2004-12-22 | 2006-06-29 | Leo Pharma A/S | Novel cyanoguanidine compounds |
| US8211912B2 (en) | 2007-09-26 | 2012-07-03 | Gemin X Pharmaceuticals Canada | Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl tranferase inhibitor |
| US8173677B2 (en) | 2007-09-26 | 2012-05-08 | Gemin X Pharmaceuticals Canada Inc. | Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor |
| WO2010088842A1 (zh) | 2009-02-06 | 2010-08-12 | 天津和美生物技术有限公司 | 含有吡啶基氰基胍的药物组合物及其制备和应用 |
| US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
| US8859594B2 (en) | 2010-10-26 | 2014-10-14 | Tianjin Hemay Bio-Tech Co., Ltd. | Polymorphs of N-(6-(4-chlorophenoxy)hexyl)-N′-cyano-N″-(4-pyridyl)guanidine, and preparation thereof and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4530693A (en) * | 1992-08-13 | 1994-03-15 | Upjohn Company, The | Cyanoguanidines as potassium channel blockers |
| GB9219472D0 (en) * | 1992-09-15 | 1992-10-28 | Leo Pharm Prod Ltd | Chemical compounds |
| DK0741708T3 (da) * | 1994-01-28 | 1999-01-18 | Upjohn Co | Cyanoguanidiner som K-kanal-blokkere |
| GB9711125D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| AU1494702A (en) * | 2000-11-21 | 2002-06-03 | Leo Pharma As | Cyanoguanidine prodrugs |
-
1997
- 1997-05-29 GB GBGB9711123.1A patent/GB9711123D0/en active Pending
-
1998
- 1998-05-15 JP JP50011199A patent/JP4349476B2/ja not_active Expired - Lifetime
- 1998-05-15 CN CN98805591A patent/CN1121389C/zh not_active Expired - Lifetime
- 1998-05-15 DK DK98924052T patent/DK0984936T3/da active
- 1998-05-15 RO RO99-01253A patent/RO119880B1/ro unknown
- 1998-05-15 KR KR1019997011148A patent/KR100549631B1/ko not_active Expired - Lifetime
- 1998-05-15 WO PCT/DK1998/000193 patent/WO1998054141A1/en not_active Ceased
- 1998-05-15 NZ NZ501266A patent/NZ501266A/en not_active IP Right Cessation
- 1998-05-15 ES ES98924052T patent/ES2206931T3/es not_active Expired - Lifetime
- 1998-05-15 EP EP98924052A patent/EP0984936B1/en not_active Expired - Lifetime
- 1998-05-15 CA CA002292775A patent/CA2292775C/en not_active Expired - Lifetime
- 1998-05-15 DE DE69817810T patent/DE69817810T2/de not_active Expired - Lifetime
- 1998-05-15 HU HU0003823A patent/HUP0003823A3/hu unknown
- 1998-05-15 AU AU76383/98A patent/AU733000B2/en not_active Expired
- 1998-05-15 CZ CZ19994240A patent/CZ293275B6/cs not_active IP Right Cessation
- 1998-05-15 AT AT98924052T patent/ATE248819T1/de not_active IP Right Cessation
- 1998-05-15 RU RU99128101/04A patent/RU2194697C2/ru active
- 1998-05-15 PL PL98337059A patent/PL190249B1/pl not_active IP Right Cessation
- 1998-05-15 PT PT98924052T patent/PT984936E/pt unknown
- 1998-05-15 US US09/424,631 patent/US6346520B1/en not_active Expired - Lifetime
-
2002
- 2002-02-04 US US10/061,204 patent/US6646129B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT984936E (pt) | 2004-02-27 |
| CA2292775A1 (en) | 1998-12-03 |
| CZ9904240A3 (cs) | 2001-01-17 |
| RO119880B1 (ro) | 2005-05-30 |
| CN1258277A (zh) | 2000-06-28 |
| EP0984936A1 (en) | 2000-03-15 |
| GB9711123D0 (en) | 1997-07-23 |
| US20020107400A1 (en) | 2002-08-08 |
| ES2206931T3 (es) | 2004-05-16 |
| HUP0003823A3 (en) | 2001-09-28 |
| EP0984936B1 (en) | 2003-09-03 |
| DE69817810T2 (de) | 2004-07-01 |
| PL337059A1 (en) | 2000-07-31 |
| AU733000B2 (en) | 2001-05-03 |
| ATE248819T1 (de) | 2003-09-15 |
| AU7638398A (en) | 1998-12-30 |
| CZ293275B6 (cs) | 2004-03-17 |
| HUP0003823A2 (en) | 2001-03-28 |
| CA2292775C (en) | 2009-10-13 |
| JP4349476B2 (ja) | 2009-10-21 |
| NZ501266A (en) | 2001-09-28 |
| WO1998054141A1 (en) | 1998-12-03 |
| KR20010013164A (ko) | 2001-02-26 |
| JP2001526692A (ja) | 2001-12-18 |
| DE69817810D1 (de) | 2003-10-09 |
| HK1027568A1 (en) | 2001-01-19 |
| US6646129B2 (en) | 2003-11-11 |
| US6346520B1 (en) | 2002-02-12 |
| CN1121389C (zh) | 2003-09-17 |
| KR100549631B1 (ko) | 2006-02-08 |
| PL190249B1 (pl) | 2005-11-30 |
| RU2194697C2 (ru) | 2002-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0202463D0 (sv) | Novel compounds | |
| NO20044995L (no) | Heterosykliske forbindelser | |
| DK0984938T3 (da) | Cyanoguanidiner som celleproliferationsinhibitorer | |
| NO20066055L (no) | Pyridinderivater | |
| DE60226469D1 (de) | Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren | |
| ATE253545T1 (de) | Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren | |
| DE60334536D1 (de) | Furylverbindungen | |
| DE69928697D1 (de) | Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren | |
| NO20044731L (no) | Kinolin- og isokinolinderivater fremgangsmate for fremstilling derav og anvendelse derav som betennelseshemmere | |
| NO20051100L (no) | Pyrazolsammensetninger anvendelige som GSK-3-inhibitorer | |
| ATE477256T1 (de) | Thienylverbindungen | |
| DE60034961D1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| DE60230127D1 (de) | Inhibitoren von integrin alpha-v-beta-6 | |
| NO20051051L (no) | Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler | |
| ATE248819T1 (de) | Cyanoguanidine als zellproliferation inhibitoren | |
| AR062176A1 (es) | Derivados de nicotinamida, una composicion farmaceutica que los comprende y su uso para tratar enfermedades asociadas con miosina de musculo liso o miosina no muscular | |
| GB0308201D0 (en) | Novel compounds | |
| BG103867A (en) | Cyanoguanidines as cell proliferation inhibitors | |
| SE0302756D0 (sv) | Novel Compounds | |
| ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| TW200628153A (en) | Novel compounds | |
| SE0202461D0 (sv) | Novel compounds | |
| DE502004007738D1 (de) | Stilben-derivate und deren verwendung in arzneimitteln | |
| NO20055749L (no) | Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer |